CacheBy
Thermo Fisher Scientific VEGF-164 Polyclonal Antibody
원본

Thermo Fisher Scientific VEGF-164 Polyclonal Antibody

상품 한눈에 보기

Rat VEGF-164 단백질을 인식하는 Goat Polyclonal 항체로, WB, IHC(F), Neutralization에 사용 가능. 항원 친화 크로마토그래피로 정제되었으며, 동결건조 형태로 제공. 연구용으로 혈관신생 관련 연구에 적합.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 03. 오전 12:49
Thermo Fisher Scientific PA547026 VEGF-164 Polyclonal Antibody 100 ug pk판매 단위 pk ·
재고 확인 필요
740,000원VAT 포함 814,000원

Thermo Fisher Scientific · Thermo Fisher Scientific VEGF-164 Polyclonal Antibody

Applications and Tested Dilutions

Application Tested Dilution
Western Blot (WB) 0.1 µg/mL
Immunohistochemistry (Frozen) (IHC (F)) 5–15 µg/mL
Neutralization (Neu) 0.2–0.6 µg/mL

Product Specifications

항목 내용
Species Reactivity Rat
Host / Isotype Goat / IgG
Class Polyclonal
Type Antibody
Immunogen Mouse myeloma cell line NS0-derived recombinant rat VEGF164 (Ala27–Arg190)
Conjugate Unconjugated
Form Lyophilized
Concentration 0.2 mg/mL
Purification Antigen affinity chromatography
Storage Buffer PBS with 5% trehalose
Contains No preservative
Storage Conditions -20°C, Avoid freeze/thaw cycles
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2609356

Product Specific Information

  • In direct ELISAs, approximately 20% cross-reactivity with recombinant human VEGF165 and VEGF121 is observed.
  • Less than 2% cross-reactivity with VEGF-B, VEGF-C, VEGF-D (human and mouse) is observed.
  • Reconstitute at 0.2 mg/mL in sterile PBS.
  • Endotoxin level: <0.10 EU per 1 µg of antibody (LAL method).

Target Information

VEGF-164 encodes vascular endothelial growth factor, a key regulator of angiogenesis.
This protein is implicated in cancer, cardiovascular disease, and diabetic retinopathy.
Targeting VEGF-164 is an important strategy in developing therapeutics for angiogenesis-related diseases.


For Research Use Only. Not for use in diagnostic procedures.
Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.